The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/29827
StudyName: Eligibility HER2/Neu Over-expressing Locally Advanced Breast Cancer NCT01007942
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 22.04.2018
License: Creative Commons BY 4.0

----

Description: 
Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01007942
